Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health. Read the full Wisconsin State Journal story here.
- Wisconsin-born medtech company Cubismi chosen to take part in Microsoft startup programJune 24, 2021
- InsideWis: In rush to rein in tech’s ‘Big Four,’ don’t hurt young companiesJune 24, 2021
- WisPolitics: Gov. Evers announces more than $140 million for Wisconsin’s tourism and entertainment industriesJune 24, 2021
- WisBusiness: Wisconsin Manufacturers and Commerce survey highlights the workforce shortage plaguing employersJune 24, 2021
- WEDC presents 5 episode ‘Wisconsin Employer Vaccine Forum’ seriesJune 24, 2021